42
Special Populations
6.1.1. Chronic Management After SCAD
COR LOE
Recommendations
1 C-LD 1. In patients with CCD who have experienced SCAD,
counseling should be provided regarding potential triggers
and risk of SCAD recurrence.
2a C-LD 2. In patients with CCD who have experienced SCAD,
evaluation for underlying vasculopathies is reasonable to
identify abnormalities in other vascular beds.
2b C-LD 3. In patients with CCD who have experienced SCAD, beta-
blocker therapy may be reasonable to reduce the incidence of
recurrent SCAD.
6.1. Existing Heart Diseases and Conditions
